Company Overview of Mithridion, Inc.
Mithridion, Inc., a biopharmaceutical company, discovers and develops drugs for central nervous system disorders. Its products include MCD-386 Pharmacology, a selective M1 muscarinic agonist for alzheimer’s disease. The company’s drugs are used for the treatment of alzheimer’s disease and schizophrenia. Mithridion, Inc. was founded in 2004 and is based in Madison, Wisconsin.
505 Science Drive
Madison, WI 53711
Founded in 2004
Key Executives for Mithridion, Inc.
Similar Private Companies By Industry
|Global Bioenergetics Technology Inc.||United States|
|UCB, Inc.||United States|
|Performance Health, LLC||United States|
|Organic Science, Inc.||United States|
|Blend Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Mithridion, Inc., please visit www.mithridion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.